Phadia US Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.0M | 88 | 31.4% |
| Food and Beverage | $794,749 | 36,437 | 24.5% |
| Honoraria | $745,839 | 422 | 23.0% |
| Consulting Fee | $546,777 | 145 | 16.9% |
| Travel and Lodging | $128,640 | 197 | 4.0% |
| Education | $2,531 | 1 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,225 | 2 | 0.1% |
| Charitable Contribution | $1,000 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CABAI 2104 Study Dynamics of SARS-CoV2 transmission and disease | $158,277 | 0 | 2 |
| Investigation of IgG4 and IgE Antibodies to the component proteins of Milk, Other Foods and inhalants associated with EoE | $125,880 | 0 | 2 |
| Development of IgG4 and IgE antibodies to food and food antigens during first 3 years of life in a random cohort | $122,376 | 0 | 2 |
| Diagnostic Performance of Boiled Milk IGE CAP in baked milk allergy in children | $97,218 | 0 | 2 |
| Investigating the Relevance of IgE to galactose (a-Gal) in coronary artery disease - CABAL 2015 CF | $61,459 | 0 | 1 |
| Improving Asthma Outcomes | $46,381 | 0 | 1 |
| Dietary Management of Adult and Childrens Eosinphilic Esophagitis: The Efficacy of dietary interventions | $45,641 | 0 | 5 |
| IDEA Investigating Duliumabs Effect on Asthma by Genotype- CABAL 1922 | $42,540 | 0 | 3 |
| Research Grant Agreement to determine the earliest risk factors for food allergy development. Evaluate sensitization to food allergens in children with FPIAP compared to healthy controls in the cohort | $40,087 | 0 | 3 |
| Dietary Management of Adult Eosinphilic Esophagitis: The Efficacy of dietary interventions | $39,287 | 0 | 8 |
| Controlling and Preventing Asthma Progression and Severity in kids with Omalizumab-Preventing Asthmas in High Risk Kids (PARK | $31,417 | 0 | 16 |
| Allergen Sensitization and Exposure Pilot | $30,640 | 0 | 2 |
| Use if Liklihood Ratios to Determine the Most Clinically and Cost Effective Predictor or Clinical Allergy | $25,000 | 0 | 1 |
| Duke Prestige Award Aeroallergen-sensitization and pulmunary function outcomes in children ith chronic respiratory disease | $25,000 | 0 | 1 |
| Advancing Understanding of the Diagnosis and Management of Childhood Allergy among Medicaid Enrolled Children | $19,890 | 0 | 1 |
| Inner City Asthma | $18,433 | 0 | 1 |
| Relevance of Der p23 to symptoms of asthma and rhinitis in an unselected birth cohort | $17,919 | 0 | 1 |
| Tryptase | $16,225 | 0 | 4 |
| Improving Technology-Assisted Recording of Asthma Control in Children | $11,693 | 0 | 10 |
| Family Member Screening for Celiac Disease | $11,519 | 0 | 2 |
| CABAL 1803 Allergen Specific Component Resolved Diagnostics and Atopic Progression Profiling in Context of Omalizumab Asthma Preventention Trial | $7,680 | 0 | 2 |
| Evaluation of the Phadia ImmunoCAP PR3, MPO and GBM | $6,912 | 0 | 1 |
| Testing the Efficacy of school based environmental intervention targeting pest allergens, mold and pollution | $4,874 | 0 | 2 |
| PARK CABAL 1803 Allergen Specific Component Resolved Diagnostics and Atopic Progression Profiling in Context of Omalizumab Asthma Preventention Trial | $4,510 | 0 | 3 |
| Diagnostic Performance of 2nd Generation tTG serological tests in different ethnic populations | $2,304 | 0 | 1 |
| CABAL 1718 The Microbiome, Asthma and Other Atopic Development in the Premature Population | $2,100 | 0 | 8 |
| Multi Allergic Pilot Study | $592.00 | 0 | 1 |
| IDEA Investigating Duliumab's Effect on Asthma by Genotype- CABAL 1922 | $165.00 | 0 | 1 |
| Baked Egg Oral Immunology for Egg Allergic Children | $90.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. Christina Canody, M.d, M.D | Pediatrics | Tampa, FL | $1,897 | $0 |
| Stanley Naides, Md, MD | Rheumatology | Dana Point, CA | $1,807 | $0 |
| Jodi Shroba, Rn, Msn, Cpnp, RN, MSN, CPNP | Pediatrics | Kansas City, MO | $1,758 | $0 |
| Mr. James Tracy, D.o, D.O | Allergy & Immunology | Omaha, NE | $1,750 | $0 |
| Dr. Renee Sullivan, Md, MD | Internal Medicine | Columbia, MO | $1,640 | $0 |
| Mallory Logsdon, Pa-C, PA-C | Physician Assistant | Lake Worth, FL | $1,636 | $0 |
| Heather O'connell, Pa-C, PA-C | Medical | Peoria, AZ | $1,625 | $0 |
| Dr. Joshua Sacha, D.o, D.O | Pediatrics | Travis Afb, CA | $1,518 | $0 |
| Leigh Schmidt, Fnp, FNP | Family | Rolling Hills Estates, CA | $1,495 | $0 |
| Jeffrey Demain, M.d, M.D | Allergy & Immunology | Anchorage, AK | $1,466 | $0 |
| Dr. Lukena Karkhanis, M.d, M.D | Allergy & Immunology | San Antonio, TX | $1,332 | $0 |
| Amanda Michaud, Pa, PA | Medical | Jacksonville, FL | $1,328 | $0 |
| Joshua Gibbs, D.o, D.O | Clinical & Laboratory Immunology | Rancho Cucamonga, CA | $1,326 | $0 |
| Mr. Nathanael Brady, D.o, D.O | Allergy & Immunology | Colorado Springs, CO | $1,250 | $0 |
| Steven Thau, M.d, M.D | Pulmonary Disease | Westport, CT | $1,250 | $0 |
| Dr. Michael Armstrong, M.d, M.D | Pediatric Otolaryngology | Richmond, VA | $1,111 | $0 |
| Dr. Theodore Kelbel, M.d, M.D | Pediatrics | Grand Rapids, MI | $1,018 | $0 |
| Dr. Noah Stern, D.o, D.O | Facial Plastic Surgery | Detroit, MI | $1,018 | $0 |
| Dr. Mercedes Gadea Lopez, M.d, M.D | Pediatrics | Lake Worth, FL | $860.02 | $0 |
| Madhurima Sanka, D.o, D.O | Allergy & Immunology | Pinellas Park, FL | $849.55 | $0 |
| Dr. Frederick Herman, M.d, M.D | Allergy & Immunology | Henderson, NV | $741.64 | $0 |
| Dr. Jorge Kutugata, M.d, M.D | Pediatrics | Weslaco, TX | $680.51 | $0 |
| Sergei Belenky, Md, MD | Allergy & Immunology | Pittsburgh, PA | $642.31 | $0 |
| Thomas Platts Mills, M.d, M.D | Allergy | Charlottesville, VA | $641.99 | $0 |
| Dr. William Marasovich, Md Dds, MD DDS | Otolaryngology | Sewickley, PA | $628.08 | $0 |
Top Products
- ImmunoCAP $3.0M
- Phadia 250 $96,837
Associated Products (4)
- ImmunoCAP $3.0M
- Phadia 250 $96,837
- ELIA $61,440
- EliA $60,836
Payment Categories
- Food & Beverage $794,749
- Consulting $546,777
- Travel & Lodging $128,640
- Research $1.0M
About Phadia US Inc.
Phadia US Inc. has made $3.2M in payments to 24,019 healthcare providers, recorded across 37,293 transactions in the CMS Open Payments database. In 2024, the company paid $339,519. The top product by payment volume is ImmunoCAP ($3.0M).
Payments were distributed across 201 medical specialties. The top specialty by payment amount is Allergy & Immunology ($534,776 to 704 doctors).
Payment categories include: Food & Beverage ($794,749), Consulting ($546,777), Research ($1.0M), Travel & Lodging ($128,640).
Phadia US Inc. is associated with 4 products in the CMS Open Payments database, including ImmunoCAP, Phadia 250, and ELIA.